Conceptio › Archive › NCBI PubMed Central
NCBI PubMed Centralopen access

Multitargeted comparative evaluation suggests 2-Aoeobenoxmide shows favourable in silico binding compared to Tucatinib against ERα, HER2, AKT1, EGFR, and PIK3CA in breast cancer.

Al-Qahtani MH et al. · 2026
NCBI PubMed Central · Papers · License: Open Access · 2026
Open Source ↗Direct PDF ↓
computer-science-education
computer science education
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗
Record · ID 671213
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.